CVS Health Corporation (CVS) Stake Boosted by Twin Capital Management Inc

Lloyd Doyle
October 31, 2017

LSV Asset Management now owns 4,579,916 shares of the pharmacy operator's stock worth $359,523,000 after purchasing an additional 1,404,384 shares during the period.

Campbell Soup Company (CPB) exchanged hands at an unexpectedly high level of 5.01 million shares over the course of the day. Finally, TB Alternative Assets Ltd. acquired a new stake in shares of CVS Health Corporation during the 2nd quarter valued at about $121,000. Aperio Group, LLC now owns 813,347 shares valued at $66,141,000. As of the end of the quarter Raymond James Financial Services Advisors, Inc. had bought a total of 34,546 shares growing its position 8.2%. National Pension Service now owns 549,474 shares of the pharmacy operator's stock worth $56,997,000 after buying an additional 22,401 shares during the period. Jackson Grant Investment Advisers Inc. now owns 2,881 shares of the pharmacy operator's stock valued at $232,000 after acquiring an additional 18 shares during the period. It gives investors a clue on how effective the company is in converting the money it has to invest into net income. On average, equities analysts expect that CVS Health Corporation will post $5.85 EPS for the current fiscal year. If you are viewing this news story on another domain, it was copied illegally and reposted in violation of USA and global copyright legislation. The original version of this news story can be read at

Heading into the stock price potential, CVS Health Corporation needs to grow just 27.83% to cross its median price target of $87.5. However, technicians believes that a higher ratio would indicate the likelihood of a constant augmentation of the company's share price. Following the transaction, the director now owns 3,258 shares in the company, valued at approximately $259,401.96.

In other CVS Health Corporation news, EVP Thomas M. Moriarty sold 90,267 shares of the stock in a transaction on Monday, September 11th. The shares were sold at an average price of $83.14, for a total transaction of $7,128,673.02. Following the transaction, the chief operating officer now directly owns 119,555 shares in the company, valued at $9,939,802.70. The disclosure for this sale can be found here.

What Historical Figures Say About CVS Health Corporation (NYSE: CVS)? The stock touched 52-week High of $85.49 on 11/03/16 and 52-week Low of $68.16 on 10/30/17.

The most current P/E ratio is 13.64 and the market cap is 69.58B.

CVS Health Corporation (NYSE:CVS) last released its quarterly earnings data on Tuesday, August 8th. Next quarter's EPS is forecasted at $1.91 with next year's EPS projected to be $6.35.

CVS Health Corporation's ROI is valued at 9.90% relatively measuring the profitability on the investment.

13 number of analysts have estimated the sales of the company for the quarter ending Nov 6, 2017, analysts estimated mean sale target of 46855.8 million while high and low sale targets are estimated at 48102.7 million and 46057.3 million respectively. During the same period in the previous year, the firm earned $1.32 EPS. The company's quarterly revenue was up 4.5% compared to the same quarter past year. In the latest earnings report the EPS was $5.02 and is estimated to be $5.88 for the current year with 1,016,564,000 shares now outstanding.

The business also recently disclosed a quarterly dividend, which was paid on Thursday, November 3rd. Shareholders of record on Tuesday, October 24th will be given a dividend of $0.50 per share. The ex-dividend date is Monday, October 23rd. The dividend payment will be $0.500 per share for the quarter which comes to $2.00 on an annualized basis. CVS Health Corporation's dividend payout ratio is presently 39.92%.

Analysts are speculating a 59.24% move, based on the high target price ($109) for the shares that is set to reach in the next 12 months. BidaskClub lowered CVS Health Corporation from a hold rating to a sell rating in a report on Friday, August 25th.

As of now, the increased share price of CVS Health Corporation makes it a lucrative buy for investors. Elefante Mark B boosted its holdings in CVS Health Corporation by 0.7% during the second quarter. Five research analysts have rated the stock with a hold rating, thirteen have assigned a buy rating and one has given a strong buy rating to the company's stock. The Company provides pharmacy care for the senior community through Omnicare, Inc.

Other reports by Iphone Fresh

Discuss This Article